MetaADEDB 2.0 @ LMMD
Reaction to azo-dyes
(UMLS:C0853042)
UMLS ID:
C0853042
MeSH ID:
N/A
Synonym(s)
1.
Reaction to azo-dyes
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1ThyroxineFAERS: 16US FAERS
2AmoxicillinFAERS: 3US FAERS
32-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chlorideFAERS: 2US FAERS
4IbuprofenFAERS: 2US FAERS
5ParoxetineFAERS: 2US FAERS
6ThyroxineFAERS: 2US FAERS
7montelukastFAERS: 2US FAERS
8AlprazolamFAERS: 1US FAERS
9AspirinFAERS: 1US FAERS
10Atomoxetine HydrochlorideFAERS: 1US FAERS
11AzithromycinFAERS: 1US FAERS
12BaclofenFAERS: 1US FAERS
13Chloraprep One-stepFAERS: 1US FAERS
14DiazepamFAERS: 1US FAERS
15Duloxetine HydrochlorideFAERS: 1US FAERS
16EstradiolFAERS: 1US FAERS
17FinasterideFAERS: 1US FAERS
18FluoxetineFAERS: 1US FAERS
19GadoliniumFAERS: 1US FAERS
20LabetalolFAERS: 1US FAERS
21LamotrigineFAERS: 1OFFSIDES
US FAERS
22LisinoprilFAERS: 1US FAERS
23LorcetFAERS: 1US FAERS
24MemantineFAERS: 1US FAERS
25Methylene BlueFAERS: 1US FAERS
26MethylphenidateFAERS: 1US FAERS
27NifedipineFAERS: 1US FAERS
28NuvaRingFAERS: 1US FAERS
29OxycodoneFAERS: 1US FAERS
30ParoxetineFAERS: 1US FAERS
31PenicillinsFAERS: 1US FAERS
32PrednisoneFAERS: 1US FAERS
33PrimidoneFAERS: 1US FAERS
34ProgesteroneFAERS: 1US FAERS
35PropranololFAERS: 1US FAERS
36SertralineFAERS: 1US FAERS
37SulfamethoxazoleFAERS: 1US FAERS
38TopiramateFAERS: 1US FAERS
39ValacyclovirFAERS: 1US FAERS
40Valproic AcidFAERS: 1US FAERS
41amitriptyline, chlordiazepoxide drug combinationFAERS: 1US FAERS
42gadobutrolFAERS: 1US FAERS
43gadodiamideFAERS: 1US FAERS
44hydrochlorothiazide, lisinopril drug combinationFAERS: 1US FAERS
45ioxilanFAERS: 1US FAERS
46niraparibFAERS: 1US FAERS
47EpinephrineOFFSIDES
48RabeprazoleCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.